FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080180919> ?p ?o ?g. }

• W3080180919 endingPage "1297" @default.
• W3080180919 startingPage "1289" @default.
• W3080180919 abstract "Summary Background The risk of lymphoma in patients with inflammatory bowel disease (IBD) treated with anti‐TNF agents remains unclear. Aim To assess the comparative risk of lymphoma with anti‐TNF agents and/or thiopurines in IBD Methods We searched PubMed, EMBASE and Cochrane Library to identify studies that evaluated lymphoproliferative disorders associated with anti‐TNF agents with or without thiopurines. The risk of lymphoma was assessed through four comparator groups: combination therapy (anti‐TNF plus thiopurine), anti‐TNF monotherapy, thiopurine monotherapy and control group. Pooled incidence rate ratios (IRR) were estimated through Poisson‐normal models. Results Four observational studies comprising 261 689 patients were included. As compared with patients unexposed to anti‐TNF and thiopurines, those exposed to anti‐TNF monotherapy, thiopurine monotherapy or combination therapy had pooled IRR (per 1000 patient‐years) of lymphoma of 1.52 (95% CI: 1.06‐2.19; P = 0.023), 2.23 (95% CI: 1.79‐2.79; P < 0.001) and 3.71 (95% CI: 2.30‐6.00; P ≤ 0.01), respectively. The risk of lymphoma associated with combination therapy was higher than with thiopurines or anti‐TNF alone with pooled IRR of 1.70 (95% CI: 1.03‐2.81; P = 0.039) and 2.49 (95% CI: 1.39‐4.47; P = 0.002), respectively. The risk did not differ between anti‐TNF monotherapy and thiopurine monotherapy with pooled IRR of 0.72 (95% CI: 0.48‐1.07; P = 0.107). All observational studies were of high quality according to the Newcastle‐Ottawa scale. Conclusions There is an increased risk of lymphoma in IBD patients treated with anti‐TNF agents, either alone or when combined with thiopurines." @default.
• W3080180919 created "2020-09-01" @default.
• W3080180919 creator A5004592109 @default.
• W3080180919 creator A5008259618 @default.
• W3080180919 creator A5017740815 @default.
• W3080180919 creator A5024460514 @default.
• W3080180919 creator A5027255239 @default.
• W3080180919 creator A5065623345 @default.
• W3080180919 date "2020-08-25" @default.
• W3080180919 modified "2023-10-18" @default.
• W3080180919 title "Systematic review with meta‐analysis: comparative risk of lymphoma with anti‐tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease" @default.
• W3080180919 cites W1957194282 @default.
• W3080180919 cites W1974943298 @default.
• W3080180919 cites W2000908943 @default.
• W3080180919 cites W2004608617 @default.
• W3080180919 cites W2019886362 @default.
• W3080180919 cites W2020640954 @default.
• W3080180919 cites W2023433479 @default.
• W3080180919 cites W2024162533 @default.
• W3080180919 cites W2029520632 @default.
• W3080180919 cites W2070246874 @default.
• W3080180919 cites W2071427170 @default.
• W3080180919 cites W2074007950 @default.
• W3080180919 cites W2088513474 @default.
• W3080180919 cites W2092863985 @default.
• W3080180919 cites W2100942700 @default.
• W3080180919 cites W2105532585 @default.
• W3080180919 cites W2112639375 @default.
• W3080180919 cites W2122849467 @default.
• W3080180919 cites W2126807394 @default.
• W3080180919 cites W2147378461 @default.
• W3080180919 cites W2148361291 @default.
• W3080180919 cites W2161374186 @default.
• W3080180919 cites W2165107045 @default.
• W3080180919 cites W2166360124 @default.
• W3080180919 cites W2274061818 @default.
• W3080180919 cites W2587130863 @default.
• W3080180919 cites W2588460151 @default.
• W3080180919 cites W2767910653 @default.
• W3080180919 cites W2793442523 @default.
• W3080180919 cites W2797152839 @default.
• W3080180919 cites W2807186038 @default.
• W3080180919 cites W2810053223 @default.
• W3080180919 cites W2883829371 @default.
• W3080180919 cites W2920997743 @default.
• W3080180919 cites W2924093097 @default.
• W3080180919 cites W3017869066 @default.
• W3080180919 cites W4211167126 @default.
• W3080180919 doi "https://doi.org/10.1111/apt.16050" @default.
• W3080180919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32840893" @default.
• W3080180919 hasPublicationYear "2020" @default.
• W3080180919 type Work @default.
• W3080180919 sameAs 3080180919 @default.
• W3080180919 citedByCount "33" @default.
• W3080180919 countsByYear W30801809192020 @default.
• W3080180919 countsByYear W30801809192021 @default.
• W3080180919 countsByYear W30801809192022 @default.
• W3080180919 countsByYear W30801809192023 @default.
• W3080180919 crossrefType "journal-article" @default.
• W3080180919 hasAuthorship W3080180919A5004592109 @default.
• W3080180919 hasAuthorship W3080180919A5008259618 @default.
• W3080180919 hasAuthorship W3080180919A5017740815 @default.
• W3080180919 hasAuthorship W3080180919A5024460514 @default.
• W3080180919 hasAuthorship W3080180919A5027255239 @default.
• W3080180919 hasAuthorship W3080180919A5065623345 @default.
• W3080180919 hasConcept C126322002 @default.
• W3080180919 hasConcept C2776478404 @default.
• W3080180919 hasConcept C2776999253 @default.
• W3080180919 hasConcept C2778260677 @default.
• W3080180919 hasConcept C2779134260 @default.
• W3080180919 hasConcept C2779338263 @default.
• W3080180919 hasConcept C70917649 @default.
• W3080180919 hasConcept C71924100 @default.
• W3080180919 hasConcept C90924648 @default.
• W3080180919 hasConcept C95190672 @default.
• W3080180919 hasConceptScore W3080180919C126322002 @default.
• W3080180919 hasConceptScore W3080180919C2776478404 @default.
• W3080180919 hasConceptScore W3080180919C2776999253 @default.
• W3080180919 hasConceptScore W3080180919C2778260677 @default.
• W3080180919 hasConceptScore W3080180919C2779134260 @default.
• W3080180919 hasConceptScore W3080180919C2779338263 @default.
• W3080180919 hasConceptScore W3080180919C70917649 @default.
• W3080180919 hasConceptScore W3080180919C71924100 @default.
• W3080180919 hasConceptScore W3080180919C90924648 @default.
• W3080180919 hasConceptScore W3080180919C95190672 @default.
• W3080180919 hasIssue "8" @default.
• W3080180919 hasLocation W30801809191 @default.
• W3080180919 hasLocation W30801809192 @default.
• W3080180919 hasOpenAccess W3080180919 @default.
• W3080180919 hasPrimaryLocation W30801809191 @default.
• W3080180919 hasRelatedWork W1958497770 @default.
• W3080180919 hasRelatedWork W2089483435 @default.
• W3080180919 hasRelatedWork W2101453034 @default.
• W3080180919 hasRelatedWork W2617226102 @default.
• W3080180919 hasRelatedWork W2774027986 @default.
• W3080180919 hasRelatedWork W2781372331 @default.
• W3080180919 hasRelatedWork W2792990534 @default.
• W3080180919 hasRelatedWork W3013915831 @default.

• next